{
    "componentChunkName": "component---src-templates-docs-js",
    "path": "/colofon",
    "result": {"data":{"site":{"siteMetadata":{"title":"LTA Antistollingszorg"}},"mdx":{"fields":{"id":"46eceeae-7d79-531b-8dac-9dc0380a8d50","title":"Colofon","slug":"/colofon"},"body":"var _excluded = [\"components\"];\n\nfunction _extends() { _extends = Object.assign ? Object.assign.bind() : function (target) { for (var i = 1; i < arguments.length; i++) { var source = arguments[i]; for (var key in source) { if (Object.prototype.hasOwnProperty.call(source, key)) { target[key] = source[key]; } } } return target; }; return _extends.apply(this, arguments); }\n\nfunction _objectWithoutProperties(source, excluded) { if (source == null) return {}; var target = _objectWithoutPropertiesLoose(source, excluded); var key, i; if (Object.getOwnPropertySymbols) { var sourceSymbolKeys = Object.getOwnPropertySymbols(source); for (i = 0; i < sourceSymbolKeys.length; i++) { key = sourceSymbolKeys[i]; if (excluded.indexOf(key) >= 0) continue; if (!Object.prototype.propertyIsEnumerable.call(source, key)) continue; target[key] = source[key]; } } return target; }\n\nfunction _objectWithoutPropertiesLoose(source, excluded) { if (source == null) return {}; var target = {}; var sourceKeys = Object.keys(source); var key, i; for (i = 0; i < sourceKeys.length; i++) { key = sourceKeys[i]; if (excluded.indexOf(key) >= 0) continue; target[key] = source[key]; } return target; }\n\n/* @jsxRuntime classic */\n\n/* @jsx mdx */\nvar Meta = Card.Meta;\nvar _frontmatter = {\n  \"title\": \"Colofon\",\n  \"metaTitle\": \"Colofon\",\n  \"metaDescription\": \"De landelijke transmurale afspraak (LTA) antistollingszorg geeft richting aan de samenwerking tussen de medisch specialist, huisarts, trombosedienst, openbaar apotheker, specialist ouderengeneeskunde, tandartsen en mondhygiënisten op het gebied van antitrombotica.\",\n  \"date\": \"10-07-2020\",\n  \"type\": \"\",\n  \"previousUrl\": \"/colofon/afkortingenlijst\",\n  \"previousText\": \"Afkortingenlijst\",\n  \"nextUrl\": \"/colofon/verantwoording\",\n  \"nextText\": \"Verantwoording\"\n};\nvar layoutProps = {\n  Meta: Meta,\n  _frontmatter: _frontmatter\n};\nvar MDXLayout = \"wrapper\";\nreturn function MDXContent(_ref) {\n  var components = _ref.components,\n      props = _objectWithoutProperties(_ref, _excluded);\n\n  return mdx(MDXLayout, _extends({}, layoutProps, props, {\n    components: components,\n    mdxType: \"MDXLayout\"\n  }), mdx(\"h2\", null, \"Landelijke Transmurale Afspraak Antistollingszorg\"), mdx(Row, {\n    gutter: 16,\n    mdxType: \"Row\"\n  }, mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Initiatief\",\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlandse Internisten Vereniging\",\n      src: \"/img/logo-niv.png\",\n      style: {\n        width: '100%',\n        height: '150px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlandse Internisten Vereniging\"), mdx(\"a\", {\n    href: \"https://internisten.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(ExportOutlined, {\n    style: {\n      transform: \"rotate(-90deg)\"\n    },\n    mdxType: \"ExportOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Ondersteuning\",\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Kennisinstituut van de Federatie Medisch Specialisten\",\n      src: \"/img/logo-fms.png\",\n      style: {\n        width: '100%',\n        height: '150px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Kennisinstituut van de Federatie Medisch Specialisten\"), mdx(\"a\", {\n    href: \"https://www.demedischspecialist.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(ExportOutlined, {\n    style: {\n      transform: \"rotate(-90deg)\"\n    },\n    mdxType: \"ExportOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Financiering\",\n    size: \"small\",\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Stichting Kwaliteitsgelden Medisch Specialisten (SKMS)\"), mdx(\"a\", {\n    href: \"https://www.demedischspecialist.nl/onderwerp/skms?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(ExportOutlined, {\n    style: {\n      transform: \"rotate(-90deg)\"\n    },\n    mdxType: \"ExportOutlined\"\n  }))))), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"In samenwerking met\"), mdx(Row, {\n    gutter: 16,\n    mdxType: \"Row\"\n  }, mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlandse Vereniging voor Cardiologie\",\n      src: \"/img/logo-nvvc.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h5\", null, \"Nederlandse Vereniging voor Cardiologie\"), mdx(\"a\", {\n    href: \"https://www.nvvc.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(ExportOutlined, {\n    style: {\n      transform: \"rotate(-90deg)\"\n    },\n    mdxType: \"ExportOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlands Huisartsen Genootschap\",\n      src: \"/img/logo-nhg.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h5\", null, \"Nederlands Huisartsen Genootschap\"), mdx(\"a\", {\n    href: \"https://www.nhg.org?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(ExportOutlined, {\n    style: {\n      transform: \"rotate(-90deg)\"\n    },\n    mdxType: \"ExportOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Harteraad\",\n      src: \"/img/logo-harteraad.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h5\", null, \"Harteraad\"), mdx(\"a\", {\n    href: \"https://www.harteraad.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(ExportOutlined, {\n    style: {\n      transform: \"rotate(-90deg)\"\n    },\n    mdxType: \"ExportOutlined\"\n  }))))), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"Geautoriseerd door\"), mdx(Tag, {\n    color: \"green\",\n    style: {\n      marginBottom: \"24px\"\n    },\n    mdxType: \"Tag\"\n  }, \"10-07-2020\"), mdx(\"ul\", null, mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Internisten Vereniging\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlands Huisartsen Genootschap\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging voor Cardiologie\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Harteraad\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Federatie Nederlandse Trombosediensten\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Kennisinstituut Mondzorg\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging voor Klinische Geriatrie\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging van Keel-Neus-Oorheelkunde en Heelkunde van het Hoofd-Halsgebied\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging van Maag-Darm-Leverartsen\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging voor Neurologie\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging van Spoedeisende Hulp Artsen\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging voor Heelkunde\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging van Ziekenhuisapothekers\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Nederlandse Vereniging voor Anesthesiologie\")), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"Samenstelling van de werkgroep\"), mdx(\"ul\", null, mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Prof. dr. M.V. (Menno) Huisman, internist-vasculaire geneeskunde, voorzitter, NIV\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. L.M. (Laura) Faber, internist-hematoloog, NIV\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. G.J. (Geert-Jan) Geersing, huisarts, NHG\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"G.H. (Aafke) Snoeijen, huisarts / kaderhuisarts Hart- \", \"&\", \" Vaatziekten, NHG\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. M.E.W. (Martin) Hemels, cardioloog \\u2013 elektrofysioloog, NVVC\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. M.A. (Marc) Brouwer, cardioloog, NVVC\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"A. (Anne) Kors-Walraven MSc, beleidsadviseur, Harteraad (tot juni 2019)\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"A. (Annemarie) Auwerda, beleidsadviseur, Harteraad (vanaf juni 2019)\")), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"Samenstelling van de klankbordgroep\"), mdx(\"ul\", null, mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Prof. dr. F.R. (Fred) Rozema, MKA-chirurg, KIMO\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. J. (Jip) de Jong, epidemioloog-huisarts n.p., NHG\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. S.H. (Steven) Renes, anesthesioloog-pijnarts, NVA\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. A.M. (Arno) Wiersema, vaatchirurg, NvVH\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Drs. J.N. (Joyce) Wouts, AIOS SEH, NVSHA\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. M.E. (Maarten) Tushuizen, maag-darm-leverarts, NVMDL\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Drs. M.H.W. (Michiel) van Beek, klinisch geriater, NVKG\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"B.E. (Liesbeth) Bosma, ziekenhuisapotheker, NVZA\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Drs. A. (Annemieke) Horikx, apotheker, KNMP\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Prof. dr. H. (Hugo) ten Cate, internist-vasculaire geneeskunde, voorzitter bestuur, FNT\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"Dr. E.J. (Ewoud) van Dijk, neuroloog, voorzitter bestuur, NVN\")), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"Belangenverklaring\"), mdx(\"p\", null, \"De Code ter voorkoming van oneigenlijke be\\xEFnvloeding door belangenverstrengeling is gevolgd. Alle werkgroepleden hebben schriftelijk verklaard of zij in de laatste drie jaar directe financi\\xEBle belangen (betrekking bij een commercieel bedrijf, persoonlijke financi\\xEBle belangen, onderzoeksfinanciering) of indirecte belangen (persoonlijke relaties, reputatiemanagement) hebben gehad. Gedurende de ontwikkeling of herziening van een module worden wijzigingen in belangen aan de voorzitter doorgegeven. De belangenverklaring wordt opnieuw bevestigd tijdens de commentaarfase.\"), mdx(\"p\", null, \"Een overzicht van de belangen van werkgroepleden en het oordeel over het omgaan met eventuele belangen vindt u in onderstaande tabel. De ondertekende belangenverklaringen zijn op te vragen bij het secretariaat van het Kennisinstituut van de Federatie Medisch Specialisten.\"), mdx(SelectPerson, {\n    mdxType: \"SelectPerson\"\n  }), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"p\", null, \"App door \", mdx(\"a\", {\n    href: \"https://www.mecosud.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noopener\"\n  }, \"Mecosud B.V.\"), \" - Powered by \", mdx(\"a\", {\n    href: \"https://www.inflowchart.com?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noopener\"\n  }, \"inFlow\"), \" (interactieve beslisbomen voor de gezondheidszorg en educatieve sector)\"));\n}\n;\nMDXContent.isMDXComponent = true;","tableOfContents":{"items":[{"url":"#landelijke-transmurale-afspraak-antistollingszorg","title":"Landelijke Transmurale Afspraak Antistollingszorg"},{"url":"#in-samenwerking-met","title":"In samenwerking met"},{"url":"#geautoriseerd-door","title":"Geautoriseerd door"},{"url":"#samenstelling-van-de-werkgroep","title":"Samenstelling van de werkgroep"},{"url":"#samenstelling-van-de-klankbordgroep","title":"Samenstelling van de klankbordgroep"},{"url":"#belangenverklaring","title":"Belangenverklaring"}]},"parent":{"relativePath":"colofon.mdx"},"frontmatter":{"parent":null,"date":"10-07-2020","nextUrl":"/colofon/verantwoording","nextText":"Verantwoording","previousUrl":"/colofon/afkortingenlijst","previousText":"Afkortingenlijst"}},"allMdx":{"edges":[{"node":{"fields":{"slug":"/afbakening","title":"Afbakening"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica","title":"Bloedingen onder antitrombotica"}}},{"node":{"fields":{"slug":"/colofon","title":"Colofon"}}},{"node":{"fields":{"slug":"/contact","title":"Contact"}}},{"node":{"fields":{"slug":"/","title":"Welkom!"}}},{"node":{"fields":{"slug":"/inleiding","title":"Inleiding"}}},{"node":{"fields":{"slug":"/literatuur","title":"Literatuur"}}},{"node":{"fields":{"slug":"/colofon/afkortingenlijst","title":"Afkortingenlijst"}}},{"node":{"fields":{"slug":"/colofon/verantwoording","title":"Verantwoording"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/gezamenlijke-besluitvorming","title":"Gezamenlijke besluitvorming"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/therapietrouw","title":"Therapietrouw"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/veelgestelde-vragen-over-doacs","title":"Veelgestelde vragen over DOACs"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/veelgestelde-vragen-over-vka","title":"Veelgestelde vragen over VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/extra-opmerkingen-endoscopische-ingrepen","title":"Extra opmerkingen endoscopische ingrepen"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/extra-opmerkingen-tandheelkundige-ingrepen","title":"Extra opmerkingen tandheelkundige ingrepen"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/overzicht-periprocedureel-bloedingsrisico","title":"Overzicht periprocedureel bloedingsrisico"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/hoog-complexe-antistolling","title":"Hoog complexe antistolling"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/laag-complexe-antistolling","title":"Laag complexe antistolling"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-dabigatran","title":"Beslisboom DOAC - dabigatran"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-factor-xa-remmers-rivaroxaban-apixaban-edoxaban","title":"Beslisboom DOAC - factor Xa-remmers, Rivaroxaban, Apixaban, Edoxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-tar","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-beleid-bij-bloedingen-voor-de-huisarts","title":"Beslisboom Beleid bij bloedingen voor de huisarts"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-doac","title":"Beslisboom DOAC"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-tar","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/bloeding-onder-lmwh-ongefractioneerde-heparine","title":"Bloeding onder LMWH/ ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-apixaban","title":"Beslisboom Apixaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-dabigatran","title":"Beslisboom Dabigatran"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-edoxaban","title":"Beslisboom Edoxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-rivaroxaban","title":"Beslisboom Rivaroxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-dipyridamol","title":"Beslisboom DAPT ASA en dipyridamol"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-prasugrel-clopidogrel-ticagrelor","title":"Beslisboom DAPT ASA en prasugrel, clopidogrel, ticagrelor"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-monotherapie-clopidogrel-of-asa","title":"Beslisboom monotherapie Clopidogrel of ASA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/dual-antiplatelet-therapy-dapt-behandeling","title":"Dual Antiplatelet Therapy (DAPT) behandeling"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/minimale-duur-onderbreken-en-herstarten-dapt","title":"Minimale duur onderbreken en herstarten DAPT"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/aanbevelingen-overbrugging-en-herstarten-vka","title":"Aanbevelingen overbrugging en herstarten VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/doac/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/doac/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/lmwh/dosering-lmwh-bij-verminderde-nierfunctie","title":"Dosering LMWH bij verminderde nierfunctie"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/lmwh/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/tar/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/tar/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/vka/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/vka/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-dabigatran/schematisch","title":"Beslisboom DOAC- dabigatran"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-factor-xa-remmers-rivaroxaban-apixaban-edoxaban/schematisch","title":"Beslisboom DOAC - factor Xa-remmers, Rivaroxaban, Apixaban, Edoxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine/schematisch","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-tar/schematisch","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-beleid-bij-bloedingen-voor-de-huisarts/schematisch","title":"Beslisboom Beleid bij bloedingen voor de huisarts"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-doac/schematisch","title":"Beslisboom DOAC"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine/schematisch","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-tar/schematisch","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-apixaban/schematisch","title":"Beslisboom Apixaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-dabigatran/schematisch","title":"Beslisboom Dabigatran"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-edoxaban/schematisch","title":"Beslisboom Edoxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-rivaroxaban/schematisch","title":"Beslisboom Rivaroxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-dipyridamol/schematisch","title":"Beslisboom DAPT ASA en dipyridamol"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-prasugrel-clopidogrel-ticagrelor/schematisch","title":"Beslisboom DAPT ASA en prasugrel, clopidogrel, ticagrelor"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-monotherapie-clopidogrel-of-asa/schematisch","title":"Beslisboom monotherapie Clopidogrel of ASA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/changelog","title":"Changelog"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/informatievoorziening","title":"Informatievoorziening"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/overzicht-trombo-embolie-risico","title":"Overzicht trombo-embolie risico"}}}]}},"pageContext":{"id":"46eceeae-7d79-531b-8dac-9dc0380a8d50"}},
    "staticQueryHashes": ["1620603387","2744294623","3578633366","3706406642","4066733661"]}